Anti-Histone H3 (citrulline R2 + R8 + R17) antibody,Abcam,AB5103

Anti-Histone H3 (citrulline R2 + R8 + R17) antibody (ab5103) is a rabbit polyclonal antibody and is validated for use in IP, PepArr and WB. Anti-Histone H3 (citrulline R2 + R8 + R17) antibody (ab5103) was first used in a scientific publication in 2004 and has been cited over 595 times in peer reviewed journals. It's performance in Western blot, immunofluorescence and IHC in human and mouse samples is trusted by the scientific community. Abcam's high quality validation processes ensure Anti-Histone H3 (citrulline R2 + R8 + R17) antibody (ab5103) has high sensitivity and specificity. Anti-Histone H3 (citrulline R2 + R8 + R17) antibody (ab5103) has 27 independent reviews from customers. Anti-Histone H3 (citrulline R2 + R8 + R17) antibody (ab5103) specifically detects Histone H3 Citrulline-R2, Citrulline-R8, Citrulline-R17 (UniProt ID: P68431; Molecular weight: 16kDa) and is sold in 100 µg selling sizes. Top cited antibody for this target with >800 citations. This antibody is a key tool in cancer research, particularly in understanding histone citrullination's role in tumorigenesis and is widely used in studies of gene expression, DNA repair and autoimmune diseases like rheumatoid arthritis and lupus, involving protein arginine deiminases (PADs) and NETosis. Histone hypercitrullination is reported to play a role the progression of various cancers, including multiple myeloma, acute myeloid leukaemia, lung cancer and hepatocellular carcinoma.